Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis
ItalyA Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials
ItalyStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
ItalyStudy Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
ItalyStudy Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer
ItalyStudy for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination
ItalyStudy Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma
ItalyStudy Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older
ItalyStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
ItalyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
ItalyStudy of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly
ItalyStudy on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
